|
|
||||||||
Articles |
a USDA, ARS, Roman L. Hruska U.S. Meat Animal Research Center, Clay Center, Nebraska 68933
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
One component of the mechanism controlling folate delivery to these and other tissues is a group of folate binding proteins (FBPs)/folate receptors (FRs) [5]. The soluble FBPs are thought to transport and protect folic acid in extracellular fluids. Membrane-bound FRs are thought to be involved in specific uptake of folic acid by cells. In mice and humans, cDNAs for two different types of folate receptor (FR-
and -ß) have been characterized [68]. In humans, a third, secreted form (FR-
) has also been reported [9]. Receptor forms are anchored to the cell membrane by a glycophosphatidylinositol (GPI) linkage site present in the C-terminal end of the protein [10, 11]. The secreted form does not have a glycophosphatidylinositol linkage site [12]. Receptor forms can be liberated from cell membranes either by proteolysis [13] or by cleavage of the phosphatidylinositol linkage site by phospholipase C [10]. Thus, all forms are potentially capable of being released from cells. Serum [14], bovine milk [15], and pig uterine flushings [16, 17] contain FBPs, but their origins (receptor or secreted form), and therefore mechanisms governing control of their concentrations, have not been investigated.
Our laboratory is interested in factors influencing conceptus development and fetal erythropoiesis during early pregnancy in swine. It has been demonstrated by Western blotting that the amount of FBP increases dramatically from Day 10 to 15 of pregnancy in uterine flushings of swine [17]. The objective of the current study was to clone the cDNA for this protein to begin to understand the mechanisms governing intrauterine concentrations of FBP and therefore folate delivery to the conceptus during pregnancy in pigs.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
The 3' and 5' ends of the cDNA for FBP were isolated using rapid amplification of cDNA ends (RACE). For 3'-RACE, total RNA isolated from a Day 30 pregnant gilt was reverse-transcribed (Table 1), and the resulting product was then amplified with the forward 1 and reverse 1 primers indicated in Table 1. This product was then reamplified using the above reverse primer and forward 2 as the forward primer, and the product was then subcloned into PCR-II vector and sequenced in both directions.
For 5'-RACE, a modification of the procedure of Apte and Siebert [18] was used. Briefly, total RNA from endometrium of a Day 30 pregnant gilt was reverse-transcribed using the primer in Table 1. RNA was degraded, and cDNA was separated from free nucleotides using glass milk as described, lyophilized, and redissolved in 10 µl sterile water. One-microliter aliquots of this solution were then used in a ligation reaction using T4 RNA ligase and the four different linker oligonucleotides listed in Table 1. The resulting products were then amplified using the forward primers 14 (Table 1), respectively, as forward 5'-RACE primers, and the reverse primer 1 as the reverse primer. Resultant products were electrophoresed and Southern-blotted as previously described (not shown), and the products from the two forward primers generating the best signal (forward 2 and 4) were subcloned into pNoTA/T7 vector (5 Prime
3 Prime, Boulder, CO) and sequenced. To further evaluate possible divergence in the 5' untranslated region (UTR) of each mRNA, the above polymerase chain reaction (PCR) product was reamplified using the appropriate forward 5'-RACE primer and reverse primers 2 and 3, which were specific to each cDNA. These products were subcloned into PCR-II vector and sequenced. To confirm the cDNA sequences generated, primers designed to span the coding regions were generated and used to amplify each mRNA. Products were subcloned into PCR-II vector and sequenced in both directions. At least three separate clones for each cDNA were completely sequenced. The sequence reported is the majority sequence obtained.
Northern Blotting
Total RNA was isolated, using RNeasy, from endometrium of gilts (3 per day) from Days 10, 13, and 15 of the estrous cycle or pregnancy and Days 24, 30, and 40 of pregnancy. Total RNA was also isolated from spleen, lung, kidney, liver, and placenta from two additional Day 30 pregnant gilts. Five micrograms total RNA was electrophoresed in MOPS (3-[N-morpholino] propane-sulfonic acid)/formaldehyde gels, and the gels were then electroblotted onto Hybond membranes. Membranes were probed sequentially with probes specific for the 3' ends of the cDNAs for putative secreted and membrane-bound forms of endometrial FBP. As a control for RNA loading, blots were then probed with a glyceraldehyde phosphate dehydrogenase (GAPDH) cDNA (corresponding to nucleotides 641964, Genbank Accession No. AF017079). Probes were generated by PCR in the presence of [32P]CTP using the 3'-RACE clones for each FBP cDNA type as template and the oligonucleotides forward 1 and reverse 1 (Table 1) for secreted FBP (sFBP) and forward 2 and reverse 2 for membrane-bound FBP (mFBP). Blots were hybridized with Rapid Hyb along with 1 x 106 cpm radiolabeled probe per milliliter at 65°C for 2 h and then washed twice with double-strength SSC, 0.1% SDS at room temperature and twice again with 0.5-strength SSC, 0.1% SDS at 55°C (secreted form) or 60°C (membrane form). The GAPDH cDNA was obtained by reverse-transcribing 1 µg Day 30 pregnant endometrium using the primer GAAGCAGGGATGATGTTCTGG followed by PCR using the same primer and the forward primer CACGACCATGGAGAAGGC. The resulting cDNA corresponding to the correct size was cloned using PCR-II vector and sequenced in both directions. A probe was generated using the above primers, and blots were processed as described for the secreted form probe. To quantitate changes in each mRNA, autoradiographs were subjected to densitometry using a laser densitometer (Ultrascan XL; Pharmacia LKB, Piscataway, NJ).
N-Terminal Amino Acid Sequencing
Day 15 pregnant gilts were slaughtered, and the uterus was recovered. Each uterine horn was flushed with 20 ml saline. Approximately 100 ml of pooled Day 15 uterine flushings were then passed through a 5-ml column of Folate Sepharose (Sigma Chemical Co., St. Louis, MO) equilibrated in 50 mM Tris, 1 M NaCl, pH 8.2, and washed extensively using the equilibration buffer. Bound FBP was eluted using 50 mM glycine, 1 M NaCl, pH 2.8. Fractions containing protein (measured by absorbance at 280 nm) were dialyzed against distilled water and lyophilized. Protein was redissolved in distilled water at a concentration of 10 mg/ml (by absorbance at 280 nm), and 10 µl was subjected to SDS-PAGE. Gels were blotted onto polyvinylidene fluoride (PVDF) membrane (Millipore, Bedford, MA) using the procedure of Matsudaira [19]. A single molecular-weight band was present on the blot after staining with Coomassie blue dye (not shown). This band was excised from the blot and sequenced at the Protein Sequencing Core Facility, University of Nebraska, Lincoln, NE.
Statistical Analysis
Densitometric values for putative sFBP and mFBP were analyzed by ANOVA using the General Linear Models procedure of the statistical analysis system (SAS Institute, Inc., Cary, NC). The model included effects of status, day of the cycle or pregnancy, and the status-by-day interaction, with the densitometric values for GAPDH used as a covariate in each analysis. In both cases, no effect of status or status-by-day interaction was obtained, and these effects were dropped from the model. Day effects were then more fully evaluated using a set of orthogonal contrasts. Contrasts were 1) Day 10 versus Day 13; 2) Day 10 and 13 combined versus Day 15; 3) Day 24 versus Day 30; 4) Day 24 and 30 combined versus Day 40; and 5) Days 10, 13, and 15 combined versus Days 24, 30, and 40 combined.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
The 5'-RACE analysis indicated that both cDNA types were heterogeneous within their 5'-UTRs. For sFBP, 5'-RACE clones were obtained that lacked an 86-base pair (bp) portion of the 5'-UTR present in other clones. The sequences at the beginning and end of this deletion were consistent with removal of the 86-bp portion by RNA splicing. For mFBP, clones were isolated that diverged after the tenth base 5' to the putative translation start site. This divergence may also be due to differential RNA splicing.
Representative Northern blots for sFBP, mFBP, and GAPDH mRNAs are illustrated in Figure 4. Statistical analysis of densitometry data after correction using GAPDH results indicated that no status or status-by-day effects were present for either sFBP or mFBP mRNA (Fig. 5). Analysis of day effects indicated that sFBP mRNA concentrations did not change between Days 10 and 15 of the cycle and pregnancy, nor did they change from Day 24 to Day 40 of pregnancy. However, there was a decrease (p < 0.05) in sFBP mRNA from early (Days 1015) to later (2440) days. Similar to sFBP, mFBP mRNA concentrations did not differ from Day 1015 or from Day 2430. In contrast to sFBP, mFBP mRNA dramatically increased (p < 0.01) between early (Days 1015) and later (Days 2440) time periods. Northern analysis also indicated that the two mRNAs differed in expression patterns among different tissues. All tissues appeared to express low levels of sFBP mRNA, and all tissues but liver expressed mFBP. However, mRNA concentrations for sFBP appeared to be greatest in Day 1015 endometrium and spleen, while concentrations for mFBP appeared to be greater in Day 2440 endometrium and Day 30 placenta. The GAPDH mRNA levels could not be used to correct mRNA levels between tissues, because of differences in expression for each tissue (e.g., liver versus kidney).
|
|
The N-terminal sequence of FBP obtained from pooled Day 15 pregnant uterine flushings was ARAKSDMLNVXMDAKHHKPKPS, which was 100% identical to the inferred sequence for sFBP beginning at amino acid 20. This sequence differed from the inferred sequence for mFBP at 8 amino acids out of 20. These results indicate that the FBP found in intrauterine flushings corresponds to sFBP.
| DISCUSSION |
|---|
|
|
|---|
The sFBP cDNA and amino acid sequence reported here is only the second sequence reported coding for a protein that is likely to be directly secreted rather than linked to the cell membrane. The other reported amino acid sequence, human
-FR [9], is truncated before the glycophosphatidylinositol linkage site. In contrast, porcine endometrial sFBP is not truncated, but the glycophosphatidylinositol linkage site is disrupted by the presence of an N-linked glycosylation site and 3 charged amino acid residues. These modifications make the protein an unlikely substrate for glycophosphatidylinositol linkage, and the identification of the putative secreted form as the form present in the intrauterine environment by N-terminal sequencing is consistent with this protein's being an sFBP.
As previously indicated, the second type of FBP cDNA isolated from porcine endometrium was identified as a putative mFBP because the C-terminal end of the inferred amino acid sequence appears to contain an intact glycophosphatidylinositol (GPI) site. The signal sequence required for GPI linkage consists of 1020 hydrophobic amino acids in the C-terminal end of the protein [20]. The inferred mFBP amino acid sequence has 11 hydrophobic residues. During GPI linkage, the protein is cleaved and the new C-terminus is covalently linked to GPI. The linkage site is between 8 and 12 amino acids from the hydrophobic region. Previous studies indicate that the amino acids serine, glycine, alanine, aspartate, asparagine, and cysteine can all support GPI linkage [23, 24]. It has further been reported that the two amino acids C-terminal to the GPI attachment site must have small side chains [24, 25]. Putative mFBP has a serine and a glycine residue 12 and 11 amino acids, respectively, from the hydrophobic region. The serine is followed by glycine and alanine, the glycine by alanine and glycine. Thus, either site is suitable for GPI linkage. Nevertheless, determination of whether mFBP is a GPI-linked folate receptor requires confirmation using other methods.
The presence of two highly related but distinct forms of FBP/FR proteins within the endometrium and placenta of swine suggests a mechanism for transport of folates to the developing conceptus during pregnancy. The high homology of these cDNAs with bovine milk FBP suggests that the function of these and the bovine milk proteins may be to transport relatively large quantities of folate from one extracellular compartment to another. The FBP in milk is probably involved in transport of folate from the maternal blood stream to the milk. During pregnancy in swine, folates also must get from the maternal circulating blood to the extracellular environment and/or circulating blood of the developing conceptus. Because folates are negatively charged, they would not be expected to diffuse easily through biological membranes. Both the uterine luminal epithelium and the trophectoderm/chorion of the developing conceptus therefore present barriers to the efficient transport of folates to fetal tissues. The mFBP in endometrium may be responsible for taking up folates from the maternal blood stream. Once inside the endometrial epithelial cell, the folate would be combined with sFBP and the complex released into the intrauterine lumen. The presence of mFBP in placenta suggests that the placenta may then take up folates via competition with sFBP within the intrauterine lumen. Binding and uptake of folate by the cell via membrane FR would most likely be favored because of intracellular enzymes that polyglutamate folates and prevent them from diffusing back out of the cell [1]. Given this scenario, the efficiency of folate transport to the developing conceptus may be governed by the concentrations of folate within the maternal blood, the concentrations of mFBP on both the endometrium and placenta, the production rate of sFBP by the endometrium, and the activity of the polyglutamating enzymes. Which of these components primarily controls the rate of folate delivery to the conceptus at various stages of pregnancy will require further investigation.
Because the rate of delivery of folate to the developing swine conceptus is probably influenced by the production of FBP/FR by the endometrium and placenta, the way in which production of each protein is controlled is of interest. Previous results indicated that FBP in the intrauterine lumen increases dramatically during early pregnancy [16, 17]. Results of the current experiment confirm that this protein corresponds to sFBP mRNA and that the increase in this protein occurs in the absence of changes in mRNA levels. Several explanations for this result are possible. One possibility is that sFBP is synthesized and stored on Day 10 and that secretion of the stored sFBP is triggered from Days 11 to 13 of the cycle and pregnancy. It has been reported that during this period of the cycle or pregnancy, secretory vesicles within the endometrium disappear [26]. Another possibility is that the increase in sFBP occurs by changes in the translation rate of the mRNA. The heterogeneous nature of the 5'-UTR suggests the possibility that differences in the 5'-UTR could cause differences in translation efficiency. In support of this possibility, Sun and Anthony [27] reported that the 5'-UTR of the human FR-
mRNA contains an 18-base cis element that is critical for translation. The human FR-
gene is known to be controlled by two promoters [28], and the 18-base cis element is located in exon 1, which would be incorporated into cDNAs transcribed from the first promoter. The mRNAs transcribed from the second promoter lack this sequence and therefore presumably would be translated less efficiently. However, no sequence corresponding to the cis element described in humans is found in the deleted portion of sFBP mRNA 5'-UTR of pigs. To search for other possible cis elements within the deleted portion of the sFBP cDNA 5'-UTR, the cDNA sequence with and without the deleted region was processed by the FOLDRNA program [29] of the GCG computer package (Genetics Computer Group, Inc., Madison, WI). The 86-base region contains a possible stem loop structure (Fig. 6) that is within 20 bases of the putative start site of translation. The free energy of the structure (-13.8 kcal) is unlikely to be great enough to directly interfere with translation [30], but this or other sites could bind proteins that may enhance or interfere with translation. Further studies are needed to determine whether the discrepancy between protein levels and mRNA levels is caused by changes in secretion, changes in translation, or an alternative mechanism.
|
In contrast to sFBP mRNA, mRNA concentrations for mFBP increased dramatically between Days 15 and 24 of pregnancy. The increase in mRNA concentration coincides with the onset of fetal liver erythropoiesis and a dramatic increase in the red blood cell concentrations in the blood supply of the developing swine fetus [31]. The temporal association of the two phenomena along with the known requirement for folate in efficient erythropoiesis suggests a role for endometrial mFBP in delivery of folate to the conceptus during a critical period of fetal development. Factors that influence production of this protein in the endometrium could therefore influence the efficiency of erythropoiesis in the swine fetus. Results indicate that at least one aspect of the control of production of this protein is via changes in mRNA concentrations, either by increased transcription of the gene, or decreased degradation of the mRNA. The heterogeneity of the 5'-untranslated region of the cDNA could be involved in either mechanism. The heterogeneity observed here could be consistent with transcription initiation at two different promoters, which has been described for FR-
from humans [28]. Alternatively, the different 5'-untranslated regions may influence degradation of the mRNA. Further experiments, including the isolation and characterization of the gene, are required to distinguish between these possibilities.
Northern analysis indicated that spleen had high concentrations of mRNA for sFBP. The function of sFBP secreted by the spleen is unknown. However, because the spleen is a site of erythropoiesis in adults and folates are required for efficient erythropoiesis to occur, sFBP may be present in the spleen to increase the local concentration of folates in order to improve the efficiency of erythropoiesis. The actual function of sFBP in spleen, endometrium, and placenta probably depends on which cells produce FBP. In situ hybridization studies are currently underway to investigate this question.
In conclusion, we have isolated and characterized cDNAs corresponding to two different FBP/FR proteins from the endometrium of swine. One was identified as a putative sFBP, on the basis of lack of an intact glycophosphatidylinositol linkage site. The other was identified as a putative mFBP, because it appeared to have an intact glycophosphatidylinositol linkage site. The sFBP corresponded to the folate binding activity found in uterine flushings. Concentrations of endometrial sFBP mRNA did not change during early pregnancy (Days 115). Concentrations of endometrial mFBP mRNA increased from Days 15 to 24 of early pregnancy. These results indicate a role for both proteins in the delivery of folate to the developing swine conceptus during early pregnancy.
| FOOTNOTES |
|---|
2 Correspondence: J.L. Vallet, Reproduction Research Unit, P.O. Box 166, State Spur 18D, Clay Center, NE 68933. FAX: 402 762 4382; vallet{at}email.marc.usda.gov ![]()
Accepted: March 2, 1999.
Received: December 29, 1998.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. L. Vallet, B. A. Freking, K. A. Leymaster, and R. K. Christenson Allelic variation in the secreted folate binding protein gene is associated with uterine capacity in swine J Anim Sci, August 1, 2005; 83(8): 1860 - 1867. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.G. Kim and J.L. Vallet Secreted and Placental Membrane Forms of Folate-Binding Protein Occur Sequentially During Pregnancy in Swine Biol Reprod, October 1, 2004; 71(4): 1214 - 1219. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |